Literature DB >> 27743931

Modulation of serotonin transporter function by kappa-opioid receptor ligands.

Santhanalakshmi Sundaramurthy1, Balasubramaniam Annamalai2, Devadoss J Samuvel3, Toni S Shippenberg4, Lankupalle D Jayanthi1, Sammanda Ramamoorthy5.   

Abstract

Kappa opioid receptor (KOR) agonists produce dysphoria and psychotomimesis. While KOR agonists produce pro-depressant-like effects, KOR antagonists produce anti-depressant-like effects in rodent models. The cellular mechanisms and downstream effector(s) by which KOR ligands produce these effects are not clear. KOR agonists modulate serotonin (5-HT) transmission in the brain regions implicated in mood and motivation regulation. Presynaptic serotonin transporter (SERT) activity is critical in the modulation of synaptic 5-HT and, subsequently, in mood disorders. Detailing the molecular events of KOR-linked SERT regulation is important for examining the postulated role of this protein in mood disorders. In this study, we used heterologous expression systems and native tissue preparations to determine the cellular signaling cascades linked to KOR-mediated SERT regulation. KOR agonists U69,593 and U50,488 produced a time and concentration dependent KOR antagonist-reversible decrease in SERT function. KOR-mediated functional down-regulation of SERT is sensitive to CaMKII and Akt inhibition. The U69,593-evoked decrease in SERT activity is associated with a decreased transport Vmax, reduced SERT cell surface expression, and increased SERT phosphorylation. Furthermore, KOR activation enhanced SERT internalization and decreased SERT delivery to the membrane. These data demonstrate that KOR activation decreases 5-HT uptake by altering SERT trafficking mechanisms and phosphorylation status to reduce the functional availability of surface SERT. Copyright Â
© 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Clearance; Kappa opioid receptor; Phosphorylation; Serotonin; Serotonin transporter; Trafficking

Mesh:

Substances:

Year:  2016        PMID: 27743931      PMCID: PMC5148672          DOI: 10.1016/j.neuropharm.2016.10.011

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  77 in total

Review 1.  The dynorphin/κ-opioid receptor system and its role in psychiatric disorders.

Authors:  H A Tejeda; T S Shippenberg; R Henriksson
Journal:  Cell Mol Life Sci       Date:  2011-10-16       Impact factor: 9.261

2.  kappa-opioid receptor expression defines a phenotypically distinct subpopulation of astroglia: relationship to Ca2+ mobilization, development, and the antiproliferative effect of opioids.

Authors:  J A Gurwell; M J Duncan; K Maderspach; A Stiene-Martin; R P Elde; K F Hauser
Journal:  Brain Res       Date:  1996-10-21       Impact factor: 3.252

3.  Presynaptic opioid receptors on noradrenergic and serotonergic neurons in the human as compared to the rat neocortex.

Authors:  Benjamin Berger; Anna Katharina Rothmaier; Franziska Wedekind; Josef Zentner; Thomas J Feuerstein; Rolf Jackisch
Journal:  Br J Pharmacol       Date:  2006-06-05       Impact factor: 8.739

4.  Elevated serotonin transporter binding in major depressive disorder assessed using positron emission tomography and [11C]DASB; comparison with bipolar disorder.

Authors:  Dara M Cannon; Masanori Ichise; Denise Rollis; Jacqueline M Klaver; Shilpa K Gandhi; Dennis S Charney; Husseini K Manji; Wayne C Drevets
Journal:  Biol Psychiatry       Date:  2007-08-02       Impact factor: 13.382

5.  Mitogenic signaling via endogenous kappa-opioid receptors in C6 glioma cells: evidence for the involvement of protein kinase C and the mitogen-activated protein kinase signaling cascade.

Authors:  L M Bohn; M M Belcheva; C J Coscia
Journal:  J Neurochem       Date:  2000-02       Impact factor: 5.372

6.  Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants.

Authors:  S Ramamoorthy; R D Blakely
Journal:  Science       Date:  1999-07-30       Impact factor: 47.728

7.  Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization.

Authors:  S Ramamoorthy; A L Bauman; K R Moore; H Han; T Yang-Feng; A S Chang; V Ganapathy; R D Blakely
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

8.  Dual excitatory and inhibitory effects of opioids on intracellular calcium in neuroblastoma x glioma hybrid NG108-15 cells.

Authors:  W Jin; N M Lee; H H Loh; S A Thayer
Journal:  Mol Pharmacol       Date:  1992-12       Impact factor: 4.436

9.  The kappa-opioid agonist U69,593 blocks cocaine-induced enhancement of brain stimulation reward.

Authors:  Hilarie C Tomasiewicz; Mark S Todtenkopf; Elena H Chartoff; Bruce M Cohen; William A Carlezon
Journal:  Biol Psychiatry       Date:  2008-07-17       Impact factor: 13.382

10.  Increase of human platelet serotonin uptake by atypical histamine receptors.

Authors:  J M Launay; D Bondoux; M J Oset-Gasque; S Emami; V Mutel; M Haimart; C Gespach
Journal:  Am J Physiol       Date:  1994-02
View more
  7 in total

1.  Histamine Receptors Regulate the Activity, Surface Expression, and Phosphorylation of Serotonin Transporters.

Authors:  Balasubramaniam Annamalai; Durairaj Ragu Varman; Rebecca E Horton; Lynette C Daws; Lankupalle D Jayanthi; Sammanda Ramamoorthy
Journal:  ACS Chem Neurosci       Date:  2020-01-22       Impact factor: 4.418

Review 2.  Traumatic Stress-Induced Vulnerability to Addiction: Critical Role of the Dynorphin/Kappa Opioid Receptor System.

Authors:  Claire Leconte; Raymond Mongeau; Florence Noble
Journal:  Front Pharmacol       Date:  2022-04-27       Impact factor: 5.988

Review 3.  Targeting opioid dysregulation in depression for the development of novel therapeutics.

Authors:  Caroline A Browne; Irwin Lucki
Journal:  Pharmacol Ther       Date:  2019-04-30       Impact factor: 12.310

4.  Dysbiosis contributes to chronic constipation development via regulation of serotonin transporter in the intestine.

Authors:  Hailong Cao; Xiang Liu; Yingying An; Guoqiong Zhou; Yanrong Liu; Mengque Xu; Wenxiao Dong; Sinan Wang; Fang Yan; Kui Jiang; Bangmao Wang
Journal:  Sci Rep       Date:  2017-09-04       Impact factor: 4.379

Review 5.  Kappa Opioid Receptor Mediated Differential Regulation of Serotonin and Dopamine Transporters in Mood and Substance Use Disorder.

Authors:  Durairaj Ragu Varman; Lankupalle D Jayanthi; Sammanda Ramamoorthy
Journal:  Handb Exp Pharmacol       Date:  2022

6.  Amygdala dynorphin/κ opioid receptor system modulates depressive-like behavior in mice following chronic social defeat stress.

Authors:  Gui-Ying Zan; Xiang Sun; Yu-Jun Wang; Rui Liu; Chen-Yao Wang; Wei-Jia Du; Liu-Bin Guo; Jing-Rui Chai; Qing-Lin Li; Zhi-Qiang Liu; Jing-Gen Liu
Journal:  Acta Pharmacol Sin       Date:  2021-05-25       Impact factor: 6.150

7.  Glycogen synthase kinase-3ß supports serotonin transporter function and trafficking in a phosphorylation-dependent manner.

Authors:  Durairaj Ragu Varman; Lankupalle D Jayanthi; Sammanda Ramamoorthy
Journal:  J Neurochem       Date:  2020-09-07       Impact factor: 5.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.